Promising
Lipid / vascular (statins etc.): protect nerve tissue in secondary progressive MS
secondary progressive MS · Lipid / vascular (statins etc.)
A controlled phase 2 trial was positive. Phase 2 trials are small and often measure early markers, so this is a signal, not proof.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 140
How the verdict was reached
Positive in phase 2 only
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| MS-STAT | Phase 2 | 140 | 2008 | Met its main goal | Counted |
Counted: 1. Will count later: 0. Not counted: 0.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Promising
Related hypotheses
Assembled by software from public sources.